Quarterly Result13 Nov 2025, 07:57 pm
Chandra Bhagat Pharma Ltd. Approves Un-Audited Financial Result for H1 2025
AI Summary
Chandra Bhagat Pharma Ltd. announced the outcome of its Board Meeting held on 13th November, 2025. The Board approved the Un-Audited Financial Result for the half year ended on 30th September, 2025. The review report was provided by the Statutory Auditor in compliance with Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015. The 'Trading Window' for trading in the shares of the Company will open after 48 hours from the Announcement of Financial Statement for the Directors and Key Managerial Personnel/Designated Employees/ Connected person of the Company as defined in the code of conduct for prohibition of Insider Trading of the Company.
Key Highlights
- Chandra Bhagat Pharma Ltd. approved the Un-Audited Financial Result for the half year ended on 30th September, 2025.
- The review report was provided by the Statutory Auditor in compliance with Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015.
- The 'Trading Window' for trading in the shares of the Company will open after 48 hours from the Announcement of Financial Statement for the Directors and Key Managerial Personnel/Designated Employees/ Connected person of the Company as defined in the code of conduct for prohibition of Insider Trading of the Company.
Price Impact
More from CBPL